A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers. [electronic resource]
Producer: 20020327Description: 3912-9 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- pharmacokinetics
- Anticarcinogenic Agents -- pharmacokinetics
- Cholestanols -- pharmacokinetics
- Dose-Response Relationship, Drug
- Fatigue -- chemically induced
- Female
- Humans
- Liver -- drug effects
- Male
- Metabolic Clearance Rate
- Middle Aged
- Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.